The South Korea Epilepsy Market Size is anticipated to reach USD 29.5 Million by 2035, growing at a CAGR of 9.38% from 2025 to 2035. Rising rates of epilepsy, government awareness campaigns, improvements in antiepileptic medications, the growth of telemedicine, and individualized treatment plans particularly for children and drug-resistant cases are all contributing factors to this increase.

The South Korea Epilepsy Market Size is anticipated to reach USD 29.5 Million by 2035, growing at a CAGR of 9.38% from 2025 to 2035. Rising rates of epilepsy, government awareness campaigns, improvements in antiepileptic medications, the growth of telemedicine, and individualized treatment plans particularly for children and drug-resistant cases are all contributing factors to this increase.